These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35146837)

  • 81. Two-stage revision and systemic antifungal therapy of Candida glabrata primary prosthetic hip infection successfully treated: a case report.
    Pasticci MB; Papalini C; Leli A; Bruno G
    J Med Case Rep; 2019 May; 13(1):151. PubMed ID: 31109363
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The problems of urinary tract infections with Candida spp. aetiology in women.
    Tomczak H; Szałek E; Grześkowiak E
    Postepy Hig Med Dosw (Online); 2014 Aug; 68():1036-9. PubMed ID: 25228512
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Epidemiological and microbiological evaluation of nosocomial infections caused by Candida species].
    Erdem F; Tuncer Ertem G; Oral B; Karakoç E; Demiröz AP; Tülek N
    Mikrobiyol Bul; 2012 Oct; 46(4):637-48. PubMed ID: 23188577
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Efficacy of micafungin in treating four premature infants with candidiasis.
    Kawaguchi C; Arai I; Yasuhara H; Sano R; Nishikubo T; Takahashi Y
    Pediatr Int; 2009 Apr; 51(2):220-4. PubMed ID: 19405920
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hospital-associated funguria: analysis of risk factors, clinical presentation and outcome.
    Carvalho M; Guimarães CM; Mayer JR; Bordignon GP; Queiroz-Telles F
    Braz J Infect Dis; 2001 Dec; 5(6):313-8. PubMed ID: 11980593
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A; Luque S; Grau S; Agrifoglio A; Cachafeiro L; Herrero E; Asensio MJ; Sánchez SM; Roberts JA
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5914-21. PubMed ID: 27458229
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Candida urinary tract infections: treatment options.
    Malani AN; Kauffman CA
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):277-84. PubMed ID: 17402842
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Micafungin for therapy of invasive candidiasis in solid organ transplant recipients].
    Fortún-Abete J
    Rev Iberoam Micol; 2009 Mar; 26(1):65-8. PubMed ID: 19463280
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Yeasts isolated from nosocomial urinary infections: antifungal susceptibility and biofilm production.
    de Freitas AR; Baeza LC; Faria MG; Dota KF; Godoy Martínez P; Svidzinski TI
    Rev Iberoam Micol; 2014; 31(2):104-8. PubMed ID: 23810785
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC; Ter Heine R; Schouten JA; Hunfeld NG; van Leeuwen HJ; Verweij PE; de Lange DW; Pickkers P; Brüggemann RJ
    Clin Pharmacokinet; 2017 Oct; 56(10):1197-1206. PubMed ID: 28144840
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Urinary tract infections in children younger than 5 years of age: epidemiology, diagnosis, treatment, outcomes and prevention.
    Schlager TA
    Paediatr Drugs; 2001; 3(3):219-27. PubMed ID: 11310718
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Impact of Catheter-Associated Urinary Tract Infection (CA-UTI) in Critically Ill Children in the Pediatric Intensive Care Unit.
    Samraj RS; Stalets E; Butcher J; Deck T; Frebis J; Helpling A; Wheeler DS
    J Pediatr Intensive Care; 2016 Mar; 5(1):7-11. PubMed ID: 31110876
    [No Abstract]   [Full Text] [Related]  

  • 94. Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study.
    Timsit JF; Leverger G; Milpied N; Gachot B
    Mycoses; 2020 May; 63(5):443-451. PubMed ID: 32048344
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Micafungin Is an Efficient Treatment of Multi Drug-Resistant
    Javorova Rihova Z; Slobodova L; Hrabovska A
    J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682222
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit.
    Arslankoylu AE; Kuyucu N; Yilmaz BS; Erdogan S
    Ital J Pediatr; 2011 Nov; 37():56. PubMed ID: 22104492
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance.
    Gioia F; Gomez-Lopez A; Alvarez ME; Gomez-García de la Pedrosa E; Martín-Davila P; Cuenca-Estrella M; Moreno S; Fortun J
    Int J Infect Dis; 2020 Dec; 101():24-28. PubMed ID: 32937195
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
    Montejo M; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Diagnosis and management of fungal urinary tract infection.
    Kauffman CA
    Infect Dis Clin North Am; 2014 Mar; 28(1):61-74. PubMed ID: 24484575
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.